Therefore, it seems that there is a pattern of systemic inflammatory markers in patients with PD (i.e., lower levels of IL9 and higher concentrations of CRP, MIP-1β, and TNF-α) that highlights the existence of a specific inflammatory signature [38,39]. This evidence concerns the gene TNF and Parkinson disease.